Ritva Peltomaa

758 total citations
27 papers, 571 citations indexed

About

Ritva Peltomaa is a scholar working on Rheumatology, Hematology and Genetics. According to data from OpenAlex, Ritva Peltomaa has authored 27 papers receiving a total of 571 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Rheumatology, 7 papers in Hematology and 5 papers in Genetics. Recurrent topics in Ritva Peltomaa's work include Rheumatoid Arthritis Research and Therapies (20 papers), Systemic Lupus Erythematosus Research (8 papers) and Autoimmune and Inflammatory Disorders Research (6 papers). Ritva Peltomaa is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (20 papers), Systemic Lupus Erythematosus Research (8 papers) and Autoimmune and Inflammatory Disorders Research (6 papers). Ritva Peltomaa collaborates with scholars based in Finland, Sweden and Denmark. Ritva Peltomaa's co-authors include Marjatta Leirisalo‐Repo, Leena Paimela, Rainer H. Straub, Jürgen Schölmerich, T. Helve, Hannu Kautiainen, Sheryl Harvey, Karin Laas, Antti Kuuliala and Pia Isomäki and has published in prestigious journals such as Frontiers in Immunology, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

Ritva Peltomaa

26 papers receiving 546 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ritva Peltomaa Finland 13 345 122 93 74 54 27 571
Viviana Ravagnani Italy 10 137 0.4× 129 1.1× 69 0.7× 140 1.9× 136 2.5× 24 513
Daniela Opriș-Belinski Romania 11 288 0.8× 49 0.4× 150 1.6× 57 0.8× 140 2.6× 89 557
R. Confalonieri Italy 12 187 0.5× 67 0.5× 52 0.6× 129 1.7× 93 1.7× 21 727
Caleb Cornaby United States 12 208 0.6× 45 0.4× 236 2.5× 88 1.2× 75 1.4× 25 535
B. Manger Germany 10 350 1.0× 109 0.9× 66 0.7× 48 0.6× 47 0.9× 20 523
I. Llorente Spain 11 206 0.6× 29 0.2× 60 0.6× 76 1.0× 37 0.7× 35 378
Joy Feld Israel 17 663 1.9× 276 2.3× 531 5.7× 82 1.1× 67 1.2× 42 854
E. Bodolay Hungary 13 251 0.7× 65 0.5× 167 1.8× 70 0.9× 354 6.6× 37 723
Yasuyuki Kamata Japan 11 125 0.4× 77 0.6× 193 2.1× 54 0.7× 39 0.7× 30 455
Linda Carli Italy 16 716 2.1× 80 0.7× 366 3.9× 51 0.7× 228 4.2× 48 977

Countries citing papers authored by Ritva Peltomaa

Since Specialization
Citations

This map shows the geographic impact of Ritva Peltomaa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ritva Peltomaa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ritva Peltomaa more than expected).

Fields of papers citing papers by Ritva Peltomaa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ritva Peltomaa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ritva Peltomaa. The network helps show where Ritva Peltomaa may publish in the future.

Co-authorship network of co-authors of Ritva Peltomaa

This figure shows the co-authorship network connecting the top 25 collaborators of Ritva Peltomaa. A scholar is included among the top collaborators of Ritva Peltomaa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ritva Peltomaa. Ritva Peltomaa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Syväranta, Suvi, Suvi Tuohinen, Miia Holmström, et al.. (2023). Myocardial T1 mapping by cardiac magnetic resonance imaging shows early myocardial changes in treatment-naive patients with active rheumatoid arthritis and positive autoantibodies. Clinical and Experimental Rheumatology. 42(7). 1368–1376. 1 indexed citations
2.
Kuuliala, Krista, Anniina Virtanen, Antti Kuuliala, et al.. (2022). Tofacitinib treatment modulates the levels of several inflammation-related plasma proteins in rheumatoid arthritis and baseline levels of soluble biomarkers associate with the treatment response. Clinical & Experimental Immunology. 210(2). 141–150. 15 indexed citations
3.
Delcoigne, Bénédicte, Lotta Ljung, Sella Aarrestad Provan, et al.. (2022). Short-term, intermediate-term and long-term risks of acute coronary syndrome in cohorts of patients with RA starting biologic DMARDs: results from four Nordic countries. Annals of the Rheumatic Diseases. 81(6). 789–797. 13 indexed citations
4.
Kuuliala, Krista, Ritva Peltomaa, Anniina Virtanen, et al.. (2021). Tofacitinib Suppresses Several JAK-STAT Pathways in Rheumatoid Arthritis In Vivo and Baseline Signaling Profile Associates With Treatment Response. Frontiers in Immunology. 12. 738481–738481. 39 indexed citations
5.
Chatzidionysiou, Katerina, Merete Lund Hetland, Thomas Frisell, et al.. (2021). Effectiveness of a Second Biologic After Failure of a Non–tumor Necrosis Factor Inhibitor As First Biologic in Rheumatoid Arthritis. The Journal of Rheumatology. 48(10). 1512–1518. 4 indexed citations
6.
Peltomaa, Ritva, et al.. (2017). Dietary Therapy in Patients With Inflammatory Arthritis.. PubMed. 23(1). 34–39. 1 indexed citations
7.
Peltomaa, Ritva, et al.. (2016). The Costs of Rheumatoid Arthritis In Finland. Value in Health. 19(7). A536–A536. 1 indexed citations
8.
Relas, Heikki, et al.. (2016). Synovial fluid detection in intra-articular injections using a bioimpedance probe (BIP) needle—a clinical study. Clinical Rheumatology. 36(6). 1349–1355. 3 indexed citations
9.
Maki, Shinya, et al.. (2015). LB0002 Novel Injection Needle with Real-Time Detection of Synovial Fluid – Exploratory Clinical Study. Annals of the Rheumatic Diseases. 74. 156–156. 1 indexed citations
10.
Paimela, Leena, et al.. (2014). Work disability in Finnish patients with rheumatoid arthritis: a 15-year follow-up.. PubMed. 32(1). 88–94. 18 indexed citations
11.
Kuuliala, Antti, Heikki Julkunen, Leena Paimela, et al.. (2013). Double-blind, randomized, placebo-controlled study of three-month treatment with the combination of ofloxacin and roxithromycin in recent-onset reactive arthritis. Rheumatology International. 33(11). 2723–2729. 6 indexed citations
12.
Aaltonen, Kalle, Liisa Virkki, Esa Jämsen, et al.. (2013). Do biologic drugs affect the need for and outcome of joint replacements in patients with rheumatoid arthritis? A register-based study. Seminars in Arthritis and Rheumatism. 43(1). 55–62. 34 indexed citations
13.
14.
Laas, Karin, Ritva Peltomaa, Kari Puolakka, Hannu Kautiainen, & Marjatta Leirisalo‐Repo. (2009). Early improvement of health-related quality of life during treatment with etanercept and adalimumab in patients with rheumatoid arthritis in routine practice.. PubMed. 27(2). 315–20. 9 indexed citations
15.
Laas, Karin, Ritva Peltomaa, Hannu Kautiainen, & Marjatta Leirisalo‐Repo. (2008). Clinical impact of switching from infliximab to etanercept in patients with rheumatoid arthritis. Clinical Rheumatology. 27(7). 927–932. 32 indexed citations
16.
Peltomaa, Ritva, et al.. (2002). Mortality in patients with rheumatoid arthritis treated actively from the time of diagnosis. Annals of the Rheumatic Diseases. 61(10). 889–894. 61 indexed citations
17.
Straub, Rainer H., Leena Paimela, Ritva Peltomaa, Jürgen Schölmerich, & Marjatta Leirisalo‐Repo. (2002). Inadequately low serum levels of steroid hormones in relation to interleukin‐6 and tumor necrosis factor in untreated patients with early rheumatoid arthritis and reactive arthritis. Arthritis & Rheumatism. 46(3). 654–662. 154 indexed citations
18.
Peltomaa, Ritva, Leena Paimela, Sheryl Harvey, T. Helve, & Marjatta Leirisalo‐Repo. (2001). Increased level of YKL-40 in sera from patients with early rheumatoid arthritis: a new marker for disease activity. Rheumatology International. 20(5). 192–196. 59 indexed citations
19.
Peltomaa, Ritva, Marjatta Leirisalo‐Repo, T. Helve, & Leena Paimela. (2000). Effect of age on 3 year outcome in early rheumatoid arthritis.. PubMed. 27(3). 638–43. 17 indexed citations
20.
Peltomaa, Ritva, Leena Paimela, T. Helve, & Marjatta Leirisalo‐Repo. (1995). Comparison of Intramuscular Gold and Sulphasalazine in the Treatment of Early Rheumatoid Arthritis:A one year prospective study. Scandinavian Journal of Rheumatology. 24(6). 330–335. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Viviana Ravagnani Breakdown of academic impact, for papers by Daniela Opriș-Belinski Breakdown of academic impact, for papers by R. Confalonieri Breakdown of academic impact, for papers by Caleb Cornaby Breakdown of academic impact, for papers by B. Manger Breakdown of academic impact, for papers by I. Llorente Breakdown of academic impact, for papers by Joy Feld Breakdown of academic impact, for papers by E. Bodolay Breakdown of academic impact, for papers by Yasuyuki Kamata Breakdown of academic impact, for papers by Linda Carli
Rankless by CCL
2026